Relationship between telomere shortening and early subjective depressive symptoms and cognitive complaints in older adults

Abstract

AbstractBackgroundTelomere length (TL) has been reported to be associated with depression and cognitive impairment in elderly. Early detection of depression and cognitive impairment is important to delay disease progression. Therefore, we aimed to identify whether TL is associated with early subjective depressive symptoms and cognitive complaints among healthy elderly subjects.MethodThis study was a multicenter, outcome assessor‐blinded, 24‐week, randomized controlled trial (RCT). Measurement of questionnaire and physical activity scores and blood sample analyses were performed at baseline and after six months of follow‐up in all study participants. Linear regression analyses were performed to identify whether early subjective depressive symptoms, cognitive complaints, and several blood biomarkers are associated with TL.ResultAltogether, 137 relatively healthy elderly individuals (60‐79 years old) were enrolled in this prospective RCT. We observed an approximate decrease of 0.06 and 0.11−0.14 kbps of TL per one point increase in the geriatric depression scale and cognitive complaint interview scores, respectively, at baseline and after six months of follow‐up. We also found an approximate decrease of 0.08−0.09 kbps of TL per one point increase in interleukin (IL)‐6 levels at baseline and after six months of follow‐up.ConclusionOur study showed that both early subjective depressive symptoms and cognitive complaints were associated with a relatively shorter TL in relatively healthy elderly individuals. In addition, based on our findings, we believe that IL‐6 plays an important role in the relationship between shortening TL and early subjective depressive symptoms and cognitive complaints.